Sharma Pawan, Saxena Komal, Mishra Sanjay, Kumar Ajay
School of Biotechnology, IFTM University, Lodhipur Rajput, Delhi Road (NH-24), Moradabad, 244001, U.P., India ; Institute of Biomedical Education and Research, Mangalayatan University, Aligarh, 202145, India.
Institute of Biomedical Education and Research, Mangalayatan University, Aligarh, 202145, India.
Bioinformation. 2014 Jun 30;10(6):334-41. doi: 10.6026/97320630010334. eCollection 2014.
Japanese encephalitis (JE), a viral disease has significantly increased worldwide especially, in the developing region due to challenges in immunization, vector control and lack of appropriate treatment methods. An effective, yet an expensive heat-killed vaccine is available for the disease. Therefore, the design and development of short peptide vaccine candidate is promising. We used immune-informatics methods to perform a comprehensive analysis of the entire JEV proteome of north Indian isolate to identify the conserved peptides binding known specific HLA alleles among the documented JEV genotypes 1, 2, 3, 4 and 5. The prediction analysis identified 102 class I (using propred I) and 118 class II (using propred) binding peptides at 4% threshold value. These predicted HLA allele binding peptides were further analyzed for potential conserved region using IEDB (an immune epitope database and analysis resource). This analysis shows that 78.81% of class II (in genotype 2) and 76.47% of HLA I (in genotype 3) bound peptides are conserved. The peptides IPIVSVASL, KGAQRLAAL, LAVFLICVL and FRTLFGGMS, VFLICVLTV, are top ranking with potential super antigenic property by binding to all HLA allele members of B7 and DR4 super-types, respectively. This data finds application in the design and development of short peptide vaccine candidates and diagnostic agents for JE following adequate validation and verification.
日本脑炎(JE)是一种病毒性疾病,在全球范围内显著增加,尤其是在发展中地区,原因在于免疫接种、病媒控制面临挑战以及缺乏适当的治疗方法。目前有一种针对该疾病的有效但昂贵的热灭活疫苗。因此,设计和开发短肽候选疫苗很有前景。我们使用免疫信息学方法对印度北部分离株的整个日本脑炎病毒(JEV)蛋白质组进行了全面分析,以确定在已记录的JEV基因型1、2、3、4和5中与已知特定HLA等位基因结合的保守肽段。预测分析在4%阈值下鉴定出102个I类(使用propred I)和118个II类(使用propred)结合肽段。使用IEDB(免疫表位数据库和分析资源)对这些预测的HLA等位基因结合肽段进行潜在保守区域的进一步分析。该分析表明,II类(基因型2中)78.81%和HLA I类(基因型3中)76.47%的结合肽段是保守的。肽段IPIVSVASL、KGAQRLAAL、LAVFLICVL和FRTLFGGMS、VFLICVLTV分别通过与B7和DR4超型的所有HLA等位基因成员结合,具有潜在的超级抗原特性,排名靠前。在经过充分验证和核实后,这些数据可应用于日本脑炎短肽候选疫苗和诊断试剂的设计与开发。